Pharmacist Outreach Reduces Therapeutic Inertia in T2D | ADA 2025
Data presented at ADA’s 85th Scientific Sessions showed patients who received physician education with clinical pharmacist outreach had significantly better A1c levels at 6 months compared to usual care.
Pharmacist-Led Diabetes Coaching Improved Glycemic Control, Reduced Expenses | ADA 2025
Abstract researchers explored whether or not a pharmacist could serve as the lead of a diabetes coaching program, aiming to reduce medical expenditures and A1C levels for at-risk patients.
Q&A: Supporting Pharmacy Technicians Through Daily Recognition
Taylor Watterson, PharmD, PhD, discusses several different ways pharmacy technician contributions can be better recognized and appreciated.
Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025
Check out our coverage from the American Pharmacists Association Annual Meeting and Exposition 2025!
Pharmacists Successfully Integrate with Multi-Professional Health Care Teams
Researchers explored pharmacists’ ability to collaborate with other health care professionals in single-disciplinary outpatient practice environments.
Q&A: Prioritizing Pharmacy Technician Well-Being
Taylor Watterson, PharmD, PhD, discusses the primary contributors to stress or frustration among pharmacy technicians and how to fix them.
Progress in Dermatology Paves the Way for Vaccine Development
Researchers reviewed current understandings of the role vaccines play in dermatology, what gaps persist, and what future research is necessary.
FDA Approves Dupilumab for Treatment of Bullous Pemphigoid
Bullous pemphigoid is a rare skin condition that causes large blisters filled with fluids that typically occur near skin creases, such as the upper thighs and armpits.
SDOH Crucial in Introducing Concept of Social Dermatology
Researchers conducted a narrative review to explore the possibility of integrating social perspectives and aspects into dermatological care and research.
Cannabis Use Linked With Increased Risk of Major Adverse Cardiovascular Events
Investigators of a study used a systematic review and meta-analysis to evaluate the risk of major adverse cardiac events related to cannabis by using real-world data.
CVS Under Investigation for Text Messages Lobbying Against Louisiana PBM Reform
Louisiana opened the investigation upon discovering a CVS text message campaign sent out to patients asking them to advocate against proposed legislation.
FDA Approves Nitisinone for Treatment of Alkaptonuria
Alkaptonuria affects approximately 1 in 250,000 to 1 million people in the United States.
Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes
The drug could also reduce chronic kidney disease when combined with insulin therapy.
FDA Approves Lenacapavir for Prevention of HIV
The decision makes the therapy the first and only twice-yearly option available in the United States for PrEP.
Gut Microbiome Composition Could Be Linked With Risk of Cognitive Impairment
In the study, the composition of the gut microbiome could also be affected by food insecurity, a known social determinant of health.
Pneumococcal Hemolytic Uremic Syndrome Increased Among Children Over Last 15 Years
Researchers explored the incidence of pneumococcal hemolytic uremic syndrome in children living in Sweden from January 2009 to December 2024.
Importance of Skin-Gut Axis Communication in Homeostasis
The review explored the “emerging” term gut-skin axis and aimed to decipher the bidirectional signaling of the skin and gastrointestinal tract during homeostatic and disease states.
Mark Cuban Cost Plus Drugs, 9amHealth Collaborate to Make Obesity Medications Affordable
The program will include branded obesity glucagon-like peptide-1 medications, which will have a transparent monthly cost.
Atogepant Shows Superiority Over Topiramate for Migraine Prevention
Topline results from a phase 3 trial showed 64.1% of patients on atogepant achieved a 50% or greater reduction in mean monthly migraine days during months 4 to 6.
Semaglutide Lowers Risk of Kidney Disease Events in Patients With Type 2 Diabetes, CKD
Real-world effectiveness data showed semaglutide reduced the risk of major kidney disease events by 26%.
Sleep Habits Could Influence Risk of Type 2 Diabetes
Investigators also found that a change in brain functional network connectivity could also be associated with type 2 diabetes risk.
Vaccine Coverage Remains Low Among Forcibly Displaced Children
Researchers conducted a systematic review and meta-analysis to estimate vaccine coverage and identify factors associated with vaccination among forcibly displaced, pediatric populations.
Hair Loss Therapy Shows Potential for Regeneration in Phase 2 Trial
PP405 targets the primary biological pathway that controls the natural hair growth cycle, separating it from existing therapies.
Pneumococcus Remains Significant Cause of Adult Mortality, Morbidity
Researchers conducted a review that provided updated evidence regarding the pneumococcal disease burden, the evolution of pneumococcal vaccines, and the latest immunization strategies.
Pharmacist Administered Flu Vaccine Increased Uptake Among Older Adults
Researchers wanted to address the potential impact of pharmacist-led influenza immunization services on vaccine uptake in older adults living in Denmark.
Q&A: How Innovation is at the Heart of this Independent Pharmacy’s Growth
Amina Abubakar, PharmD, AAHIVP, joined Drug Topics to discuss her career journey as an independent pharmacy owner and the ways in which she’s been able to grow her business.
Eli Lilly Adds Highest Doses of Zepbound to Online Pharmacy Platform
Providers can prescribe the 12.5 mg and 15 mg vials of tirzepatide starting July 7, with shipments beginning in early August.
Pharmacists Demonstrate Knowledge of Epilepsy, ASM Treatment
Researchers investigated Norwegian pharmacists to understand their expertise, and potential knowledge gaps, regarding issues of epilepsy and treatment using antiseizure medication.
Dupilumab Shows Superiority Over Omalizumab for Chronic Rhinosinusitis
This study is the first to compare 2 biologics for patients with chronic rhinosinusitis with nasal polyps and coexisting asthma.
Overdose Deaths Begin to Sustain Decline After Decades Long Increase
In 2023, drug overdose deaths sustained declines, but there are still disparities that need to be addressed to continue to decrease these numbers.